Skip to main content
logo
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.390
+0.040 (2.96%)
At close: May 12, 2026, 4:00 PM EDT
1.370
-0.020 (-1.44%)
After-hours: May 12, 2026, 7:54 PM EDT

INmune Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3741104203114182
Market Cap Growth
-79.65%-60.14%-48.74%78.40%-37.48%-21.60%
Enterprise Value
17.3717.1383.37168.3371.85122.35
Last Close Price
1.391.564.6711.266.3410.20
PE Ratio
--0.84-2.21-6.74-4.17-5.43
PS Ratio
-829.467432.121309.54304.221005.53
PB Ratio
1.830.180.535.441.892.27
P/TBV Ratio
0.150.170.485.421.892.05
P/FCF Ratio
--1.76-3.12-16.94-5.02-6.39
P/OCF Ratio
--1.84-3.12-16.94-5.02-6.39
EV/Sales Ratio
-342.665955.121085.97192.11675.99
EV/EBITDA Ratio
--0.36-1.96-5.66-2.77-4.20
EV/EBIT Ratio
--0.36-1.96-5.66-2.77-4.20
EV/FCF Ratio
--0.73-2.50-14.05-3.17-4.29
Debt / Equity Ratio
0.000.000.000.010.170.19
Debt / EBITDA Ratio
-0.04-0.02-0.01-0.35-0.59-0.52
Debt / FCF Ratio
-0.08-0.04-0.01-0.87-0.67-0.53
Net Debt / Equity Ratio
-0.08-0.10-0.10-0.68-0.61-0.74
Net Debt / EBITDA Ratio
0.460.500.480.851.422.04
Net Debt / FCF Ratio
1.001.000.622.121.622.09
Asset Turnover
-0.000.000.000.000.00
Quick Ratio
4.113.483.092.075.5518.42
Current Ratio
4.243.553.142.165.9218.95
Return on Equity (ROE)
-17.83%-21.48%-36.07%-61.63%-40.83%-53.00%
Return on Assets (ROA)
-148.84%-131.78%-88.31%-42.86%-28.56%-41.47%
Return on Invested Capital (ROIC)
671.48%3830.48%-790.05%-242.85%-141.34%-176.18%
Return on Capital Employed (ROCE)
-195.15%-168.40%-120.31%-54.36%-31.18%-43.36%
Earnings Yield
-111.77%-119.23%-45.18%-14.83%-23.97%-18.43%
FCF Yield
-54.28%-56.96%-32.06%-5.90%-19.94%-15.66%
Buyback Yield / Dilution
-22.40%-24.13%-10.92%-0.30%-11.14%-34.55%
Total Shareholder Return
-22.40%-24.13%-10.92%-0.30%-11.14%-34.55%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q